Lyfegen, which offers a platform for value-based contracting for high-cost drugs, announced it had raised $8 million in Series A funding.
The round was led by aMoon, with participation from APEX Ventures and other investors. The startup, which is headquartered in Switzerland and the U.S., offers software that aims to help pharma companies, payers, providers and medical technology companies adopt...
